Allocating recycled significance levels in group sequential procedures for multiple endpoints

被引:19
|
作者
Xi, Dong [1 ]
Tamhane, Ajit C. [2 ]
机构
[1] Novartis Pharmaceut, IIS Stat Methodol, E Hanover, NJ 07936 USA
[2] Northwestern Univ, Dept Ind Engn & Management Sci, Evanston, IL 60208 USA
关键词
Error spending function; Familywise error rate; Graphical approach; O'Brien-Fleming boundary; Pocock boundary; Recycling; CLINICAL-TRIALS; ADAPTIVE EXTENSIONS; DESIGN;
D O I
10.1002/bimj.201300157
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Graphical approaches have been proposed in the literature for testing hypotheses on multiple endpoints by recycling significance levels from rejected hypotheses to unrejected ones. Recently, they have been extended to group sequential procedures (GSPs). Our focus in this paper is on the allocation of recycled significance levels from rejected hypotheses to the stages of the GSPs for unrejected hypotheses. We propose a delayed recycling method that allocates the recycled significance level from Stage r onward, where r is prespecified. We show that r cannot be chosen adaptively to coincide with the random stage at which the hypothesis from which the significance level is recycled is rejected. Such an adaptive GSP does not always control the FWER. One can choose r to minimize the expected sample size for a given power requirement. We illustrate how a simulation approach can be used for this purpose. Several examples, including a clinical trial example, are given to illustrate the proposed procedure.
引用
收藏
页码:90 / 107
页数:18
相关论文
共 50 条
  • [1] Sample size optimization and initial allocation of the significance levels in group sequential trials with multiple endpoints
    Gou, Jiangtao
    [J]. BIOMETRICAL JOURNAL, 2022, 64 (02) : 301 - 311
  • [2] Closed testing procedures for group sequential clinical trials with multiple endpoints
    Tang, DI
    Geller, NL
    [J]. BIOMETRICS, 1999, 55 (04) : 1188 - 1192
  • [3] A group sequential Holm procedure with multiple primary endpoints
    Ye, Yining
    Li, Ai
    Liu, Lingyun
    Yao, Bin
    [J]. STATISTICS IN MEDICINE, 2013, 32 (07) : 1112 - 1124
  • [4] DESIGN OF GROUP SEQUENTIAL CLINICAL-TRIALS WITH MULTIPLE ENDPOINTS
    TANG, DI
    GNECCO, C
    GELLER, NL
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1989, 84 (407) : 776 - 779
  • [5] Hierarchical testing of multiple endpoints in group-sequential trials
    Glimm, Ekkehard
    Maurer, Willi
    Bretz, Frank
    [J]. STATISTICS IN MEDICINE, 2010, 29 (02) : 219 - 228
  • [6] Using prior information to allocate significance levels for multiple endpoints
    Westfall, PH
    Krishen, A
    Young, SS
    [J]. STATISTICS IN MEDICINE, 1998, 17 (18) : 2107 - 2119
  • [7] Some Multiplicity Adjustment Procedures for Clinical Trials with Sequential Design and Multiple Endpoints
    Luo, Xiaodong
    Quan, Hui
    [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2024, 16 (01): : 104 - 115
  • [8] Defining information fractions in group sequential clinical trials with multiple endpoints
    Xu, Tu
    Qin, Qin
    Wang, Xin
    [J]. CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2018, 10 : 77 - 79
  • [9] Design and analysis of group sequential clinical trials with multiple primary endpoints
    Kosorok, MR
    Shi, YJ
    DeMets, DL
    [J]. BIOMETRICS, 2004, 60 (01) : 134 - 145
  • [10] Adaptive group sequential procedures for multiple comparison of treatments
    Cerutti, B
    Zoubeidi, T
    Reboussin, DM
    [J]. COMMUNICATIONS IN STATISTICS-THEORY AND METHODS, 2002, 31 (05) : 781 - 793